[#item_full_content] President Trump is expected to sign an executive order that could reclassify marijuana from a Schedule I to a Schedule III drug, which would enable cannabis to be federally classified for medical use. Tilray Brands (TLRY) Chairman and CEO Irwin Simon sits down with Julie Hyman to share his outlook on his company’s THC and hemp products in relation to Congress’ latest budget bill that could see a ban on most hemp-derived THC products by late 2026. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts. Read More
